Lisa D. Earnhardt Joins Nerites Corporation Board of Directors

MADISON, Wis.--(BUSINESS WIRE)--Nerites Corporation announced today that Lisa D. Earnhardt has joined its Board of Directors. Lisa is currently President and CEO of Sinexus, Inc., a medical device company focused on Ear, Nose, and Throat applications, where she led a $20 Million Series B financing effort in 2008. Previously, Lisa served as President of the Cardiac Surgery division at Boston Scientific (formerly Guidant), and was instrumental in the divestiture of the business unit to Getinge Group for $750 Million. Lisa has a background in medical device sales and marketing, an MBA from the Kellogg School of Management, and a Bachelor of Science degree from Stanford University.

“She brings us a valuable market perspective and substantial operating experience through her knowledge of the medical device sector and her management of both large and small companies. As the company solidifies plans for additional corporate partnerships and new financing, Lisa’s strategic input will be invaluable.”

“Nerites is very pleased to welcome Lisa to the Board of Directors,” stated Chairman George Arida. “She brings us a valuable market perspective and substantial operating experience through her knowledge of the medical device sector and her management of both large and small companies. As the company solidifies plans for additional corporate partnerships and new financing, Lisa’s strategic input will be invaluable.”

Earnhardt commented: “This is a great time to join the Nerites team. Having spent many years in the surgical arena, the application of Nerites technology is readily apparent and has been validated by winning both a global partnership and numerous competitive grant awards. I look forward to helping guide Nerites towards commercial success.”

Nerites CEO, Shaun Lonergan, added: “Lisa’s background and network of contacts will be helpful in developing the company’s strategic plans and identifying new market opportunities. We’re delighted to have her counsel.”

About Nerites: Nerites Corporation develops a new generation of synthetic bio-adhesives to enhance natural tissue repair, reduce postoperative complications, and degrade safely when they are no longer needed. The hydrogel technology can be used to glue tissues together, affix medical devices in place, seal air and fluid leaks, and provide a barrier against bacteria. Properties can be “tuned” to fit each application. The technology was described with a cover article in the journal Nature (July, 2007) and was labeled “one of the top 100 scientific developments of 2007” by Discover Magazine. (www.Nerites.com)